[Effect of GBE50 on experimental arrhythmias]

Area of Science:

• Pharmacology
• Cardiovascular Research
• Natural Product Chemistry

Context:

• Arrhythmia poses a significant global health challenge, necessitating novel therapeutic strategies.
• Ginkgo leaf extract (GBE50) is explored for its potential anti-arrhythmic properties.
• Understanding the precise mechanisms of GBE50 in cardiac electrophysiology is crucial.

Purpose:

• To investigate the action and mechanism of ginkgo leaf extract (GBE50) in combating arrhythmia.
• To evaluate the efficacy of GBE50 in animal models of cardiac arrhythmia induced by aconitine and ouabain.
• To assess the effects of GBE50 on delayed afterdepolarizations (DADs) and triggered activity (TA) in guinea pig papillary muscles.

Summary:

• GBE50 significantly increased the threshold doses of ouabain and aconitine required to induce ventricular arrhythmias (VP, VT, VF, CA) in animal models.
• In guinea pig papillary muscles, GBE50 markedly suppressed ouabain-induced DADs and TA, reducing their amplitude, duration, and incidence.
• GBE50 demonstrated significant therapeutic effects on DADs, with dose-dependent reductions in amplitude and duration.

Impact:

• This study provides evidence for the anti-arrhythmic potential of GBE50.
• GBE50's inhibitory effects on DADs and TA suggest a novel mechanism for managing certain types of cardiac arrhythmias.
• Findings support further research into GBE50 as a potential therapeutic agent for arrhythmia treatment.